platinum has been researched along with lenvatinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arunachalam, A; Catherine Pietanza, M; Frederickson, AM; Zhang, I; Zhao, B | 1 |
| Asanoma, K; Hachisuga, K; Hori, E; Kato, K; Kodama, K; Maenohara, S; Ohgami, T; Okugawa, K; Onoyama, I; Yagi, H; Yahata, H; Yasunaga, M | 1 |
1 review(s) available for platinum and lenvatinib
| Article | Year |
|---|---|
Efficacy and safety of treatments for advanced thymic carcinoma after failure of first-line platinum-based chemotherapy: A systematic literature review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Sunitinib; Thymoma; Thymus Neoplasms | 2023 |
1 other study(ies) available for platinum and lenvatinib
| Article | Year |
|---|---|
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies | 2023 |